November 5, 2025 - 19:07

Genelux Corporation has shared its financial results for the third quarter of 2025, highlighting significant advancements in its lung cancer programs. The company anticipates interim data updates for these programs to be available in the fourth quarter of 2025, showcasing its commitment to developing innovative treatments in the oncology space.
In addition to progress in lung cancer, Genelux is also preparing for the release of topline data from its OnPrime Phase 3 registrational trial focused on ovarian cancer. This crucial data is expected to be disclosed in the second half of 2026, marking a pivotal moment for the company as it aims to establish its presence in the competitive oncology market.
As of September 30, 2025, Genelux reported cash, cash equivalents, short-term investments, and restricted cash totaling $21.0 million. This financial position provides a solid foundation for the company as it advances its clinical programs and continues to seek innovative solutions for cancer treatment.
August 21, 2026 - 03:11
Ballet Student Jessica Wang Makes Tiaras Her BusinessFor most ballet students, the focus is on perfecting a pirouette or landing a role in the spring showcase. For Jessica Wang, the real challenge came offstage: building a small business that makes...
August 20, 2026 - 13:00
Baldwin Park business trying to pivot after leak leaves them closedA sudden pipe leak has forced Lafayette & Rushford, a home decor store in Baldwin Park, to close its doors indefinitely. The damage from the water is significant, and the owners say they have no...
August 19, 2026 - 21:02
How Small Businesses Can Save 10% on the Supplies They Need to SucceedRunning a small business means watching every dollar, especially when it comes to routine purchases like office paper, cleaning products, or shipping boxes. These expenses add up quickly, but there...
August 19, 2026 - 04:32
Scott Seaman Selected to Crain’s Chicago Business 2026 Notable Leaders in Accounting, Consulting & LawHinshaw & Culbertson LLP has announced that Scott Seaman, a partner and co-chair of the firm`s global Insurance Services group, has been recognized by Crain`s Chicago Business as a 2026 Notable...